Volume 18, Number 4—April 2012
Dispatch
De Novo Daptomycin-Nonsusceptible Enterococcal Infections
Theodoros Kelesidis
, Romney Humphries, Daniel Z. Uslan, and David Pegues
, Romney Humphries, Daniel Z. Uslan, and David Pegues
Table 2
Antimicrobial susceptibilities of DNSE isolates from 9 patients to antimicrobial drugs with activity against Enterococcus spp., Los Angeles, California, USA, 2007–2011*
| Patient no. | Enterococcus species | MIC, μg/mL |
Synergy test |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DAP† | VAN | AMP | DOX | NIT | LZD | Q-D | TGC | CIP | GEN | STR | |||
| 1 | E. faecium | ND | >32 (R) | >64 (R) | <1 (S) | 128 (R) | 2 (S) | <0.5 (S) | <0.25 (S) | >4 (R) | S | S | |
| 2 | E. faecium | ND | >32 (R) | >64 (R) | 8 (I) | 64 (I) | 2 (S) | <0.5 (S) | <0.25 (S) | >4 (R) | R | S | |
| 3 | E. faecium | ND | 2 (S) | >64 (R) | 16 (R) | 32 (S) | 1 (S) | <0.5 (S) | <0.25 (S) | >4 (R) | R | R | |
| 4 | E. faecalis | 4 | 1 (S) | <2 (S) | 16 (R) | <16 (S) | 2 (S) | 4 (R) | <0.25 (S) | 1 (S) | S | S | |
| 5 | E. faecalis | 12 | 2 (S) | <2 (S) | 8 (I) | <16 (S) | 2 (S) | 4 (R) | <0.25 (S) | 1 (S) | S | S | |
| 6 | E. faecium | 8 | >32 (R) | >64 (R) | 8 (I) | 32 (S) | 1 (S) | 1(S) | <0.25 (S) | >4 (R) | S | S | |
| 7 | E. gallinarum | 4 | <0.5 (S) | <2 (S) | <1(S) | 32 (S) | 1 (S) | 1(S) | <0.25 (S) | <0.5 (S) | S | S | |
| 8 | E. faecium | 8 | >32 (R) | >64 (R) | 4 (S) | 64 (I) | 2 (S) | <0.5 (S) | <0.25 (S) | >4 (R) | R | S | |
| 9 | E. faecium | ND | >32 (R) | >64 (R) | 4 (S) | 64 (I) | 1 (S) | 1 (S) | <0.25 (S) | >4 (R) | R | S | |
*DNSE, daptomycin-nonsusceptible enterococci; DAP, daptomycin; VAN, vancomycin; AMP, ampicillin; DOX, doxycycline; NIT, nitrofurantoin; LZD, linezolid; Q-D, quinupristin/dalfopristin; TGC, tigecycline; CIP, ciprofloxacin; GEN, gentamicin; STR, streptomycin; NS, nonsusceptible; ND, not done; R, resistant; S, sensitive.
†By Etest.
Page created: March 14, 2012
Page updated: March 14, 2012
Page reviewed: March 14, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.